Latest News

Results from the ICON8B trial show that combined chemotherapy and bevacizumab treatment is better at preventing ovarian cancer coming back or getting worse when chemotherapy is given weekly rather than every 3 weeks.
A new animated video aimed at study participants explains what happens during a pharmacokinetics (PK) study.
In the latest Trial Talk episode, we explore the MAMS-ROCI design, a type of multi-arm multi-stage design that can be used to optimise continuous aspects of a treatment.
The D3 team have successfully completed recruitment of more than 370 children and adolescents living with HIV, ahead of schedule.
The PediCAP team have successfully recruited the 1,100 patients required for the study’s main trial, investigating more child-friendly treatment options for severe community-acquired pneumonia.